Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Han Li
Introduction
Han Li is a prominent inventor based in Little Rock, Arkansas. He has made significant strides in the field of gene therapy, particularly through his innovative methods involving adeno-associated viral (AAV) vectors. His work has the potential to revolutionize human gene therapy and improve treatment options for various genetic disorders.
Latest Patents
Han Li holds a patent for a method of gene delivery using wildtype adeno-associated viral vectors. This invention provides a novel approach to human gene therapy by utilizing AAV vectors with an essentially wildtype phenotype. The method allows for the insertion of genes of 900 bases or less into wildtype AAV, maintaining a largely wildtype phenotype. This innovation offers several advantages, including the ability to achieve high titers of vectors easily, specific integration into human chromosome 19, and the capacity for wildtype vectors to spread after their initial introduction.
Career Highlights
Han Li is affiliated with the University of Arkansas, where he conducts research and develops his innovative gene therapy methods. His work has garnered attention for its potential applications in treating genetic disorders and enhancing the efficacy of gene delivery systems.
Collaborations
Han Li has collaborated with notable colleagues, including Paul L. Hermonat and J. Gerald Quirk. These collaborations have contributed to the advancement of research in gene therapy and the development of effective gene delivery methods.
Conclusion
Han Li's contributions to the field of gene therapy through his innovative patent on AAV vectors highlight his role as a leading inventor in this area. His work continues to pave the way for advancements in genetic medicine and therapeutic interventions.